Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma von ATEFI, Mohammad, AVRAMIS, Earl, COMIN-ANDUIX, Begonya, RIBAS, Antoni, LASSEN, Amanda, WONG, Deborah J. L, ROBERT, Lidia, FOULAD, David, CERNIGLIA, Michael, TITZ, Bjoern, CHODON, Thinle, GRAEBER, Thomas G

Volltext

Prediction of Clinical Deterioration in Hospitalized Adult Patients with Hematologic Malignancies Using a Neural Network Model von Hu, Scott B, Wong, Deborah J L, Correa, Aditi, Li, Ning, Deng, Jane C

Volltext

Perspectives on the Treatment of Advanced Thyroid Cancer: Approved Therapies, Resistance Mechanisms, and Future Directions von Porter, Ashleigh, Wong, Deborah J

Volltext

Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b... von Gulley, James L, Dr, Rajan, Arun, MD, Spigel, David R, MD, Iannotti, Nicholas, MD, Chandler, Jason, MD, Wong, Deborah J L, MD, Leach, Joseph, MD, Edenfield, W Jeff, MD, Wang, Ding, MD, Grote, Hans Juergen, MD, Heydebreck, Anja von, PhD, Chin, Kevin, MD, Cuillerot, Jean-Marie, MD, Kelly, Karen, MD

Volltext

Impact of early detection on cancer curability: A modified Delphi panel study von Schwartzberg, Lee, Broder, Michael S, Ailawadhi, Sikander, Beltran, Himisha, Blakely, L Johnetta, Budd, G Thomas, Carr, Laurie, Cecchini, Michael, Cobb, Patrick, Kansal, Anuraag, Kim, Ashley, Monk, Bradley J, Wong, Deborah J, Campos, Cynthia, Yermilov, Irina

Volltext

Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma von CHODON, Thinle, COMIN-ANDUIX, Begoña, MCCANNEL, Tara A, ISHIYAMA, Akira, CZERNIN, Johannes, RADU, Caius G, XIAOYAN WANG, GJERTSON, David W, COCHRAN, Alistair J, CORNETTA, Kenneth, WONG, Deborah J. L, KAPLAN-LEFKO, Paula, CHMIELOWSKI, Bartosz, HAMID, Omid, SAMLOWSKI, Wolfram, COHEN, Peter A, DANIELS, Gregory A, MUKHERJI, Bijay, LILI YANG, ZACK, Jerome A, KOHN, Donald B, HEATH, James R, GLASPY, John A, KOYA, Richard C, WITTE, Owen N, BALTIMORE, David, ECONOMOU, James S, RIBAS, Antoni, ZHONGQI WU, AUERBACH, Martin, NG, Charles, AVRAMIS, Earl, SEJA, Elizabeth, VILLANUEVA, Arturo

Volltext

Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial von Le Tourneau, Christophe, Hoimes, Christopher, Zarwan, Corrine, Wong, Deborah J, Bauer, Sebastian, Claus, Rainer, Wermke, Martin, Hariharan, Subramanian, von Heydebreck, Anja, Kasturi, Vijay, Chand, Vikram, Gulley, James L

Volltext

Tipifarnib in recurrent, metastatic HRAS‐mutant salivary gland cancer von Hanna, Glenn J., Guenette, Jeffrey P., Chau, Nicole G., Sayehli, Cyrus M., Wilhelm, Christian, Metcalf, Robert, Wong, Deborah J., Brose, Marcia, Razaq, Mohammad, Pérez‐Ruiz, Elisabeth, Cohen, Ezra E. W., Aggarwal, Rahul, Scholz, Catherine, Gualberto, Antonio, Ho, Alan L.

Volltext

A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol von Courtney, P Travis, L Santoso, Milisuryani, Savjani, Ricky R, K Reddy, Vishruth, Chai-Ho, Wanxing, Velez Velez, Maria A, J Wong, Deborah, Palodichuk, Christy, Basehart, T Vincent, P O'Connell, Dylan, Cao, Minsong, Telesca, Donatello, Chin, Robert K

Volltext

Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study von Atkins, Michael B, Hodi, F Stephen, Thompson, John A, McDermott, David F, Hwu, Wen-Jen, Lawrence, Donald P, Dawson, Nancy A, Wong, Deborah J, Bhatia, Shailender, James, Marihella, Jain, Lokesh, Robey, Seth, Shu, Xinxin, Homet Moreno, Blanca, Perini, Rodolfo F, Choueiri, Toni K, Ribas, Antoni

Volltext

Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress von Tsoi, Jennifer, Robert, Lidia, Paraiso, Kim, Galvan, Carlos, Sheu, Katherine M., Lay, Johnson, Wong, Deborah J.L., Atefi, Mohammad, Shirazi, Roksana, Wang, Xiaoyan, Braas, Daniel, Grasso, Catherine S., Palaskas, Nicolaos, Ribas, Antoni, Graeber, Thomas G.

Volltext

Phase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors von Blank, Christian U, Wong, Deborah J, Ho, Thai H, Bauer, Todd M, Lee, Carrie B, Bene-Tchaleu, Fabiola, Zhu, Jing, Zhang, Xiaosong, Cha, Edward, Sznol, Mario

Volltext

Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma von Atefi, Mohammad, Titz, Bjoern, Avramis, Earl, Ng, Charles, Wong, Deborah J L, Lassen, Amanda, Cerniglia, Michael, Escuin-Ordinas, Helena, Foulad, David, Comin-Anduix, Begonya, Graeber, Thomas G, Ribas, Antoni

Volltext

Durable response of anaplastic thyroid carcinoma to FS118, a bispecific LAG-3/PD-L1 antibody, after checkpoint inhibitor progression: a case report von Kroloff, Maxwell J, Holz, Josefin-Beate, Stern, Omer, Shepherd, Christopher J, Morrow, Michelle, Kayitalire, Louis, Wong, Deborah J

Volltext

Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial von Sacco, Assuntina G, Chen, Ruifeng, Worden, Francis P, Wong, Deborah J L, Adkins, Douglas, Swiecicki, Paul, Chai-Ho, Wanxing, Oppelt, Peter, Ghosh, Debanjali, Bykowski, Julie, Molinolo, Alfredo, Pittman, Emily, Estrada, M Valeria, Gold, Kathryn, Daniels, Gregory, Lippman, Scott M, Natsuhara, Amanda, Messer, Karen, Cohen, Ezra E W

Volltext

Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial von Guigay, Joël, Lee, Keun-Wook, Patel, Manish R, Daste, Amaury, Wong, Deborah J, Goel, Sanjay, Gordon, Michael S, Gutierrez, Martin, Balmanoukian, Ani, Le Tourneau, Christophe, Mita, Alain, Vansteene, Damien, Keilholz, Ulrich, Schöffski, Patrick, Grote, Hans Juergen, Zhou, Dongli, Bajars, Marcis, Penel, Nicolas

Volltext

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial von Migden, Michael R, Khushalani, Nikhil I, Chang, Anne Lynn S, Lewis, Karl D, Schmults, Chrysalyne D, Hernandez-Aya, Leonel, Meier, Friedegund, Schadendorf, Dirk, Guminski, Alexander, Hauschild, Axel, Wong, Deborah J, Daniels, Gregory A, Berking, Carola, Jankovic, Vladimir, Stankevich, Elizabeth, Booth, Jocelyn, Li, Siyu, Weinreich, David M, Yancopoulos, George D, Lowy, Israel, Fury, Matthew G, Rischin, Danny

Volltext

Therapeutic Advances in Advanced Basal Cell Carcinoma von Alkassis, Samer, Shatta, Maya, Wong, Deborah J

Volltext

Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas von Kirtane, Kedar, St John, Maie, Fuentes-Bayne, Harry, Patel, Sandip P, Mardiros, Armen, Xu, Han, Ng, Eric W, Go, William Y, Wong, Deborah J, Sunwoo, John B, Welch, John S

Volltext

Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations von Ho, Alan L, Brana, Irene, Haddad, Robert, Bauman, Jessica, Bible, Keith, Oosting, Sjoukje, Wong, Deborah J, Ahn, Myung-Ju, Boni, Valentina, Even, Caroline, Fayette, Jerome, Flor, Maria José, Harrington, Kevin, Kim, Sung-Bae, Licitra, Lisa, Nixon, Ioanna, Saba, Nabil F, Hackenberg, Stephan, Specenier, Pol, Worden, Francis, Balsara, Binaifer, Leoni, Mollie, Martell, Bridget, Scholz, Catherine, Gualberto, Antonio

Volltext